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Abstract: Perinatal asphyxia (PA) is still a serious health problem associated with neuronal loss and morbidity. PA 
pathophysiology implies oxidative stress, cell damage and over activation of inflammatory response. The absence of an 
established treatment for PA encourages research on neuroprotective mechanisms. Oleoylethanolamide (OEA), a 
cannabinoid agonist that exerts anti-inflammatory actions through PPAR activation, could be a possible target for 
neuroprotection. However, its role in perinatal hypoxic brain injury remains still unknown. In this study, we evaluated the 
behavioral consequences of OEA treatment in 30 days-old asphyctic rats. Results indicated that rats subjected to OEA 
administration showed an improvement in exploratory locomotion. This data suggests a possible neuroprotective role of 
OEA in severe perinatal asphyxia modifications.  
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1. INTRODUCTION 
Perinatal asphyxia (PA) is a neonatal complication 
associated with an impaired gas exchange [1]. The 
most common reasons for this health problem are: 
abruption of the placenta, compression of the umbilical 
cord, abnormal uterine contractions or failure of the 
neonate to begin breathing [2]. The incidence of severe 
PA is estimated at 1/1000 live birth in developed 
countries and 5-10/1000 live births in developing 
countries [3]. Cerebral palsy, mental retardation, and 
epilepsy are among the most common complications of 
PA [4-7], which continues to be a determinant of 
neonatal mortality and neurological morbidity [8, 9]. 
Although hypothermia and estradiol therapy have 
shown favorable results [10, 11], there is not an 
established treatment for PA. 
Regarding the pathophysiology of PA, a decrease of 
oxygen saturation implies a severe energetic crisis: a 
shift to anaerobic metabolism takes place in order to  
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preserve the fundamental demands of energy. 
However, anaerobic metabolism is inefficient for 
providing enough energy for development of neuronal 
networks and is associated to lactate accumulation and 
acidosis. These functional consequences of the 
primary insult are exacerbated by and during the re-
oxygenation period, which is necessary for survival but 
implies free radicals accumulation, oxidative stress, cell 
damage and over activation of defense mechanisms 
such as inflammatory cascades [12].  
OEA is present in human and rat brain in 
considerable amounts [13-17]. This lipid amide is a 
PPAR (alpha-type peroxisome proliferators activated 
receptor) agonist [13, 14, 18]. In experimental studies, 
OEA attenuated inflammation in wild-type mice but had 
no effect in mice deficient in PPAR. This finding 
suggests that PPAR mediates the anti-inflammatory 
action of OEA [13, 14]. In fact, the alpha-type receptor 
is expressed in several immune cells [19, 20] and 
regulates the expression of large sets of genes, 
thereby modulating important metabolic processes [21], 
such as inflammatory reactions. In addition to its anti-
inflammatory properties, OEA showed cytoprotective 
effects both in vitro and in vivo models of substantia 
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nigra dopamine neuron degeneration [22]. Besides, a 
substantial body of evidence has suggested that 
cannabinoid agonists could exert its neuroprotective 
effect modulating the inhibitory and excitatory neuro- 
transmission or inducing hypothermia [23]. However, 
the neuroprotective properties of OEA on PA remain 
still unknown. Therefore, the aim of this experimental 
work was to elucidate this issue by analyzing the beh- 
avioral effects of OEA administration in asphyctic rats.  
In the present study, we used a rat model that 
induces global severe PA [11, 24, 25]. The advantages 
of this model are 2-fold: first, it mimics the asphyxia just 
in the moment of delivery; second, it allows studying 
both the short as well as the long-term effects, since it 
is a non-invasive procedure [26, 27]. The most obvious 
and serious short-term consequence of PA observed in 
this model is mortality. At 37°C, an asphyctic period 
longer than 20 min was inevitably associated with 
death probably induced by glutamate overactivation 
and excessive free radicals release [26, 27]. Rats 
subjected to 20 min of asphyxia at 37°C showed 
chronic defects in neurotransmitters such as decrease 
in dopamine, aspartate and glutamate release monitor- 
ed by microdialysis [28]. F-actin striatal cytoskeleton 
changes were observed in post-synaptic densities of 
asphyctic rats at postnatal day 30 P30 [29] and an 
increase in the nitric oxide in neostriatum and 
neocortex at short- and long term period was also 
found [30, 31]. Alterations in cytoskeletal organization 
were observed after 4 months of PA [11]. Recently, an 
increase in the ubiquitination level and 
neurodegeneration after 6 months of PA in neostriatum 
was also registered in our laboratory [25]. Finally, 
behavioral deficit in exploration was observed after 3 
months of PA [32]. The present study was focused on 
earlier behavioral effects of PA and its possible 
recovery through OEA treatment. To accomplish this 
purpose, exploratory locomotion and anxiety levels 
were measured in the Elevated Plus Maze test at post-
natal day 30 (P30). 
2. MATERIALS AND METHODS  
2.1. Animals  
Subjects consisted of 8 pregnant Sprague Dawley 
rats obtained from the School of Veterinary Sciences’ 
central vivarium at the Universidad de Buenos Aires.  
The sample (N=24) consisted of male rat pups and 
was divided into 4 groups: asphyctic rats undergoing to 
vehicle treatment (PA20), asphyctic rats subjected to 
treatment with OEA (PA20 OEA10), control of 
cesarean delivery undergoing to vehicle treatment 
(C+), control of cesarean delivery subjected to 
treatment with OEA (C+ OEA10).  
2.2. Induction of Perinatal Asphyxia  
PA was induced in newborn rat pups delivered by 
cesarean operation. Gestational age was determined 
by vaginal smear. After the surgical site was prepared 
for surgery (shaved, cleaned, antiseptic applied), rats 
within the last day of gestation were deeply 
anesthetized with Nembutal (30 mg/ml) by i.p. injection 
of 0.1 cc per 100 grams of body weight. Their entire 
uteri containing the fetuses were taken out by 
hysterectomy, and placed in a water bath at 37°C for 
20 min (severe asphyxia). The mother rat was euthani- 
zed. Cesarean-delivered control and asphyctic pups 
were obtained from the same mother. Following PA, 
the uterus horns were rapidly opened and the pups 
were removed and stimulated to breathe on a heating 
pad by cleaning off the delivery fluid and by tactile 
stimulation with small pieces of medical wipes. In all of 
the pups the umbilical cord was tied (previous anti- 
septic applied) and left to recover on a heating pad for 
1 h. After that the pups were given to the surrogate’s 
mothers, which had delivered few hours before the 
experiment, mixing their normal litters with previously 
marked asphyctic and control pups. Experimental and 
control pups were weaned at 24 days, and transferred 
to cages with free access to food and water [11, 24, 
25]. All experiments were conducted according to the 
principles of the Guide for the Care and Use of 
Laboratory Animals (NIH Publications No. 80-23, 
revised 1996), and approved by the Institutional Animal 
Care and Use Committee at the University of Buenos 
Aires (School of Medicine) No. 4081/04). 
2.3. Oleoylethanolamide Administration  
The respective treatment was performed within the 
first hour of life by subcutaneous injection. Vehicle 
used was 1:1:9 DMSO, Tween 80 y NaCl.  
OEA dose administered was 10 mg/kg (OEA 10 
mg/kg).  
2.4. Elevated Plus Maze  
This behavioral test is validated to evaluate anxiety 
and exploration [33]. The maze consists of a black 
central platform from which four black arms radiate in 
the form of a cross. Two of the arms have a wall all 
around its perimeter and are called closed arms. The 
other two arms are open. The maze is elevated one 
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meter from the floor. Rats are placed onto the central 
platform facing an open arm. The test lasts 5 minutes 
[32].  
In the present study, the elevated plus maze test 
was carried out at P30. Dependent variables were 
measured: Time spent in open arms (index of anxiety) 
and time spent in closed arms (index of exploratory 
locomotion). Time was measured in seconds.  
3. RESULTS  
Results were expressed as means ± SEM. One-way 
ANOVA followed by post-hoc comparisons (Fisher’s 
test) were carried out. Homoscedasticity was 
previously tested. A probability was considered to be 
significant at 5% or less. Statistical analyses were 
performed using the SPSS 18.0 for windows (SPSS 
Inc., Chicago, IL, USA).  
3.1. Exploratory Locomotion 
When time spent in closed arms was analyzed, a 
significant effect of group was found (F(3,20)=4.949; 
p=0.01). Post hoc analyses revealed that time 
exploration of PA rats was significantly lower than the 
other groups: C+ Veh (p=0.001), C+ OEA10 (p=0.007) 
and PA20 OEA10 (p=0.033). Figure 1 illustrates these 
results.  
 
Figure 1: Graph showing the performance of different group 
of animals during Elevated plus Maze test (close arms). 
Perinatal asphyxia animals show a significant decrease in the 
exploration locomotion activity. This activity was recovered 
with OEA treatment. C+ = Control cesarean; PA20 = 20 
minutes of Perinatal Asphyxia; C+ OEA10 = Control 
Cesarean& OEA treatment (10 mg/kg); PA20 OEA10: 20 
minutes of Perinatal Asphyxia& OEA treatment (10 mg/kg). 
*** p0.001, ** p0.01, * p0.05 compared with PA20 group. 
3.2. Anxiety  
No significant differences between groups in terms 
of time spent in open arms were found (F (3,20)=1.554; 
p=0.232), as shown in Figure 2.  
 
Figure 2: Graph showing the performance of different group 
of animals analyzed during Elevated plus Maze test (open 
arms). No differences were observed between different 
groups. C+ = Control cesarean; PA20 = 20 minutes of 
Perinatal Asphyxia; C+ OEA10 = Control Cesarean & OEA 
treatment (10 mg/kg); PA20 OEA10: 20 minutes of Perinatal 
Asphyxia & OEA treatment (10 mg/kg). 
4. DISCUSSIONS AND CONCLUSION 
The main finding of this study is that OEA treatment 
(in a dose of 10 mg/kg) would be associated with an 
improvement in exploratory locomotion in asphyctic 
rats. Our behavioral results could be related to the 
apparent anti-inflammatory action of OEA, which is 
mediated by PPAR- [13, 14]. Consistent with this 
data, a recent study of our laboratory has shown that 
the effects of OEA could prevent neuroinflammation in 
asphyctic rats
1
. Substantial body of evidence suggests 
that in neurodegenerative diseases, the inflammatory 
process, which attempts a tissue recovery through 
microglial action, could lose its regulation and become 
a powerful factor of neuronal destruction [34]. In fact, 
damage elicited by PA implies Poly (ADP- ribose) 
polymerase 1 (PARP-1) overactivation, promoting expr- 
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ession of proinflammatory cytokines and microglial 
migration toward the site of neuronal injury. But exces- 
sive PARP-1 activation could lead to energy crisis and 
to apoptosis [12]. Therefore, the apparent anti-inflam- 
matory actions of OEA would be neuroprotective for 
perinatal hypoxic brain damage.  
In addition, we observed behavioral modifications at 
P30. This data is consistent with previous studies from 
our laboratory using the same model of PA [11, 24, 25]. 
Asphyctic animals showed a decrease in exploration 
without an alteration in anxiety at post-natal day 90 
(P90) [32]. These behavioral modifications associated 
with PA could be related to F-actin neostriatal 
cytoskeleton changes observed in post-synaptic 
densities of asphyctic rats at P30. These morphological 
modifications described in our laboratory might be one 
of the mechanisms involved in the neuronal loss 
induced by PA, since we observed dramatic synaptic 
changes with ubiquitination, degeneration and 
inflammatory modifications 6 months after induction of 
PA [25, 29]. Further studies will be carried out to 
determine if OEA might have some protective effects 
on synaptic structure and functions.  
In conclusion, OEA treatment (10 mg/kg) in 
asphyctic rats would be accompanied by an improve- 
ment in exploratory locomotion at P30. A more 
thorough understanding of neuroprotective mechani- 
sms of OEA and its behavioral effects on PA may 
contribute to obtain effective treatments for this 
neonatal complication.  
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